GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/GI Surgery/Neurogenic Diarrhoea Common After SMA Divestment in PDAC : BJS Open | Jun 2026

Neurogenic Diarrhoea Common After SMA Divestment in PDAC : BJS Open | Jun 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

Introduction: The increasing use of preoperative chemotherapy has expanded the surgical eligibility of patients with locally advanced pancreatic ductal adenocarcinoma (PDAC). Superior mesenteric artery (SMA) divestment and, in selected cases, SMA resection have become important techniques for achieving margin-negative resections in tumors involving the perivascular neural plexus.


Introduction:

The increasing use of preoperative chemotherapy has expanded the surgical eligibility of patients with locally advanced pancreatic ductal adenocarcinoma (PDAC). Superior mesenteric artery (SMA) divestment and, in selected cases, SMA resection have become important techniques for achieving margin-negative resections in tumors involving the perivascular neural plexus. However, disruption of the autonomic nerve fibers surrounding the SMA can lead to postoperative neurogenic diarrhoea, a complication that is often difficult to manage and can significantly affect postoperative recovery and quality of life.

Problem Statement:

Despite growing adoption of SMA divestment procedures, data regarding the incidence, risk factors, treatment strategies, and long-term consequences of postoperative neurogenic diarrhoea remain limited. Better understanding of this complication is essential for patient counselling, perioperative planning, and postoperative management.

Summary:

This international multicentre study provides the largest evaluation to date of neurogenic diarrhoea following pancreatic resection with SMA divestment or resection after preoperative therapy for PDAC. The investigators found that neurogenic diarrhoea is a frequent postoperative complication, affecting approximately two-thirds of patients. The risk increased substantially with the extent of SMA dissection, with the highest rates observed after more extensive circumferential divestment and SMA resection. Management strategies varied considerably across centers and included antidiarrhoeal agents, opioid-based therapies, opium tincture, and octreotide, reflecting the absence of standardized treatment protocols. Although symptom resolution was achieved in approximately half of affected patients, neurogenic diarrhoea remained a challenging postoperative issue. Reassuringly, despite its high incidence and impact on postoperative care, neurogenic diarrhoea was not associated with worse overall survival. These findings suggest that while the complication can be burdensome, it should not discourage aggressive surgical approaches when oncologically indicated. The study highlights the importance of preoperative patient counselling, early recognition of symptoms, and structured postoperative management. It also underscores the urgent need for evidence-based treatment algorithms and prospective studies aimed at optimizing the prevention and management of neurogenic diarrhoea in patients undergoing advanced pancreatic cancer surgery.

Related Q&A

Mesh Fixation and Chronic Groin Pain: BJS Open | July 2026

Introduction: Chronic postoperative inguinal pain (CPIP) remains one of the most important long-term complications after laparoscopic groin hernia repair, despite lower rates than with open surgery. Whether different mesh types and fixation methods influence the...

Collateral-Based PD Without Venous Reconstruction: Indian J Gastroenterol | July 2026

Introduction: Venous involvement is common in locally advanced pancreatic cancer and often necessitates superior mesenteric-portal vein resection with reconstruction during pancreaticoduodenectomy. However, reconstruction may not always be feasible because of extensive venous disease or unfavorable...

Robotic vs Open Pancreatoduodenectomy: BMJ | July 2026

Introduction: Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy...

Adapting Military Resilience to Modern Surgery by SOSC: An of Surgery | July 2026

Introduction: Surgery is an inherently high-stress profession, where complications, patient deaths, and difficult decisions can lead to burnout, moral injury, and mental health disorders. Inspired by the US Marine Corps' Combat and Operational Stress Control...

Vascular Resection for Pancreatic Cancer: Annals of Surgery | June 2026

Introduction: As surgical techniques and perioperative therapies have advanced, vascular resection during pancreatic cancer surgery has become increasingly common in selected patients with locally advanced disease. This study evaluated the long-term outcomes of venous and...

Drain Management After Pancreatoduodenectomy: BJS Open | June 2026

Introduction: Optimal drain management after pancreatoduodenectomy (PD) remains critical for preventing postoperative pancreatic fistula (POPF) while supporting enhanced recovery. This study proposes a dynamic, risk-adapted algorithm based on intraoperative risk and postoperative biochemical markers. Why...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer